Hemostemix Inc. (V:HEM*CA)

Business Focus: Bio Therapeutic Drugs

INK Ultra Money Free

Latest 10 SEDI filings (by transaction date) for HEM*CA within the last 6 months
[?]
Amended Filing
As of 11:59pm ET January 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 9/19 Dec 4/19 Smeenk, Thomas Direct Ownership Common Shares 10 - Acquisition in the public market 500,000 $0.010
Dec 3/19 Nov 26/19 Smeenk, Thomas Direct Ownership Common Shares 00 - Opening Balance-Initial SEDI Report 700,000  
Sign up or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by filing date) for HEM*CA within the last 6 months
[?]
Amended Filing
As of 11:59pm ET January 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 9/19 Dec 4/19 Smeenk, Thomas Direct Ownership Common Shares 10 - Acquisition in the public market 500,000 $0.010
Dec 3/19 Nov 26/19 Smeenk, Thomas Direct Ownership Common Shares 00 - Opening Balance-Initial SEDI Report 700,000  
Sign up or login above to see all SEDI filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider.
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $HEM.CA

  • No tweets found